Skip to Main Content

Paper Details

Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.
NPJ Precis Oncol
24
2019
CD45RO, IFN, IRF9, Patients, T, T-cell subsets, TILs, TNBC, interferon, interferon regulatory factor IRF9, intratumoral type I and II interferon, mouse, patient, patients, triple negative breast cancer, tumor, tumor infiltrating lymphocytes, type I IFN

Datasets

Release 1.2